A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on their level of CD4+ T-cells. An HIV-infected individual’s level of CD4+ T-cells–commonly referred to as their CD4 count–is a key measure of immune system health. The study is co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Related posts:
- Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health....
- NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute […]...
- Letsmove.gov: Healthy Choices One Day at a Time Alright, confession time: I watch a lot of bad reality TV. Please don’t judge me. For many reasons, one of my favorite shows is the Biggest Loser. I’m a health nut; I love watching the transformations; and I get a kick out of the trainers screaming their heads off. But the fact that such a […]...
- People with Disabilities Can Lead Long, Healthy Lives People with Disabilities Can Lead Long, Healthy Lives...
- Study identifies gene that suppresses cell’s immune activation A new study of prostate tumors has shown that a gene, FOXO3, suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer. One of the main problems in treating cancer by vaccine or immunotherapy is that tumors often evade the body’s immune response — and one […]...
- Vaccinating Children against Flu Helps Protect Wider Community Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well. The study was conducted to determine if immunized children could act as a barrier to limit the spread of influenza to the wider, unvaccinated community, a concept known as herd immunity....
- Medicare Mouse study shows effect of blood pressure drug on Alzheimer’s disease A drug used decades ago to treat high blood pressure has been shown to improve learning and memory in mouse models of Alzheimer’s disease, according to a new study by researchers at the National Institute on Aging (NIA), part of the National Institutes of Health. The study found that the drug, diazoxide, acted on nerve […]...
- Medicare, Study of MicroRNA, Helps NIH Scientists, Unlock Secrets of Immune Cells With the rapid and continuous advances in biotechnology, scientists are better able to see inside the nucleus of a cell to unlock the secrets of its genetic material. However, what happens outside of the nucleus has, in many ways, remained a mystery. Now, researchers with the National Institutes of Health are closer to understanding how […]...
- NIH-funded study finds new possible risk factor of heart disease, Medicare NIH-funded study finds new possible risk factor of heart disease, Medicare...
- Medicare NIH funds four clinical trials to fight antimicrobial resistance The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced four new contracts for large-scale clinical trials that address the problem of antimicrobial resistance. Over the next five to six years, these new clinical trials will evaluate treatment alternatives for diseases for which antibiotics are prescribed most […]...
- NIAID Announces New Award to Study the Effects of Radiation and Aging on the Human Immune System NIAID Announces New Award to Study the Effects of Radiation and Aging on the Human Immune System ...
- Medicare Card News: NIH Researchers Explore How Healthy, Young Adults View the Role Genetics Plays in Improving Health Most healthy young adults place greater emphasis on health habits than on genetic risk factors when considering what causes common diseases, a research team from the National Human Genome Research Institute (NHGRI) and the Henry Ford Health System in Detroit has found. The study, based on a survey of 25- to-45-year-olds, was released June 8, […]...
- Study of Health Outcomes in Autistic Children and Their Families The goal of this initiative is to describe the health and health care trajectories of individuals with autism spectrum disorders (ASD) and their families, and to evaluate the feasibility of using a large population-based database for research on risk factors for ASD. The most recent prevalence data from the Centers for Disease Control and Prevention (CDC) show that one in 110 children have a diagnosis of Autism Spectrum Disorder (ASD), an increase of 57 percent between 2002 and 2006...
- NIH Scientists Advance Universal Flu Vaccine A universal influenza vaccine — so-called because it could potentially provide protection from all flu strains for decades — may become a reality because of research led by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health....
- Genetically modified fungi kill malaria-causing parasites in mosquitoes Genetically modified fungi kill malaria-causing parasites in mosquitoes...